Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 24 entities : Novartis ag save search
Global Dermatology Drugs Market to 2027 - Industry Analysis, Trends, Market Size, and Forecasts
Published: 2021-08-24 (Crawled : 21:00) - prnewswire.com
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.63%
H: 0.42%
C: 0.28%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.17%
H: 0.12%
C: -0.83%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.24%
H: 0.12%
C: -0.05%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.66%
C: 0.41%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: -0.38%
H: 0.07%
C: -0.97%
drug market
Worldwide Protein Drugs Industry to 2026 - Prevalence of Chronic Diseases is Driving Growth
Published: 2021-08-24 (Crawled : 12:00) - prnewswire.com
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: -1.04%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.35%
H: 0.12%
C: -0.9%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -0.03%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.69%
H: 0.42%
C: 0.1%
BMRN S | $88.95 -1.24% 500K
|
Health Technology
|
| O: -0.08%
H: 2.49%
C: 2.43%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: -0.05%
H: 0.07%
C: -0.51%
disease drug growth
Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
Published: 2021-08-24 (Crawled : 06:00) - globenewswire.com
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: -1.04%
treatment t-cell
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.